D3 Current Issues in HPV Prevention

Thursday, March 11, 2010: 8:30 AM-10:15 AM
Grand Ballroom B (M4) (Omni Hotel)
Moderator:
8:30 AM
D3a
Monitoring HPV Vaccine Impact On Cervical Cancer Precursors: Preliminary Results From the HPV-IMPACT Monitoring Project
Susan Hariri, PhD1, Nasreen Abdullah, MD, MPH2, Nancy Bennett, MD, MS3, Karen Bloch, MD, MPH4, Ghinwa Dumyati, MD3, James Gaudino Jr., MD, MS, MPH, FACPM5, Sharon Jotblad, MPH6, Pamela Julian, MPH7, Diane Levine, MPH4, Linda Niccolai, PhD7, Erin Whitney, MPH6, Elizabeth Unger, MD, PhD8 and Lauri Markowitz, MD1, 1Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, 2Public Health Division, Oregon Immunization Program (formerly) and Acute & Communicable Disease (currently), Oregon Department of Human Services, Portland, OR, 3Center for Community Health, University of Rochester Medical Center, Rochester, NY, 4Department of Medicine (Infectious Diseases) and Preventive Medicine, Vanderbilt University Medical Center, Nashville, TN, 5Public Health Division-Immunization Prg and Acute & Communicable Disease Prevention, Oregon Department of Human Services, Portland, OR, 6STD Control Branch and California Emerging Infections Program, California Department of Public Health, Richmond, CA, 7Emerging Infections Program, Yale School of Public Health, New Haven, CT, 8National Center for Zoonotic, Vector-borne, and Enteric Diseases, Centers for Disease Control and Prevetion, Atlanta, GA
8:45 AM
D3b
Creating a Novel Surveillance System From Scratch: California's Human Papillomavirus (HPV) Vaccine Impact Monitoring Project (HPV-IMPACT)
Erin Whitney, MPH1, Sharon Jotblad, MPH1, Ina Park, MD, MS2, Susan Hariri, PhD, MPH3 and Heidi Bauer, MD, MS, MPH2, 1Sexually Transmitted Disease (STD) Control Branch and California Emerging Infections Program, California Department of Public Health, Richmond, CA, 2Sexually Transmitted Disease (STD) Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, 3Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA
9:00 AM
D3c
STI Vaccination: What Do Adult Women Want?
Gregory Zimet, PhD1, Lynne Sturm, PhD1, Rose Mays, PhD, RN2, Rita Bair, MD, MPH1 and Susan Rosenthal, PhD3, 1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, 2Department of Family Health Nursing, Indiana University School of Nursing, Indianapolis, IN, 3Department of Pediatrics, Columbia University, New York, NY
9:15 AM
D3d
Efficacy of GARDASIL® against External Genital Lesions Due to 14 HPV Types in Men
Anna Giuliano, PhD, Risk Assessment,Detection & Intervention, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
9:30 AM
D3e
The Cost-Effectiveness of Male Human Papillomavirus (HPV) Vaccination in the United States
Harrell Chesson, PhD, Division STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA and Lauri Markowitz, MD, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA
9:45 AM
D3f
Males Receiving HPV Test Results: A Unique Opportunity to Assess Emotional Responses in Men
Ellen Daley, PhD1, Eric Buhi, MPH, PhD1, Stephanie Marhefka, PhD1, Cheryl Vamos, PhD1, Chris Wheldon, MSPH2 and Natalie Hernandez, MPH2, 1Department of Community and Family Health, College of Public Health, University of South Florida, Tampa, FL, 2Department of Community and Family Health, College of Public Health -- University of South Florida, Tampa, FL
See more of: Oral and Poster